Beinaglutide

DRUG3 trials

Sponsors

Xijing Hospital, Beijing Hospital, Second Xiangya Hospital of Central South University

Conditions

Diabetes Mellitus, Type 2Overweight or ObesityT2DMT2DM (Type 2 Diabetes Mellitus)Type 2 Diabetes MellitusType 2 Diabetic Patients

Phase 4

The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.

Second Xiangya Hospital of Central South UniversityDiabetes Mellitus, Type 2, Overweight or Obesity

Start: 2021-05-01End: 2023-12-31Target: 120Updated: 2023-03-17

Unknown Phase

Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus

CompletedNCT03829891

Xijing HospitalType 2 Diabetes Mellitus

Start: 2018-08-07End: 2020-12-04Updated: 2022-01-19

Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients

RecruitingNCT03987308

Beijing HospitalT2DM, T2DM (Type 2 Diabetes Mellitus), Type 2 Diabetic Patients

Start: 2019-07-02End: 2025-12-31Target: 115Updated: 2025-05-02

Related Papers

The efficacy and safety of beinaglutide alone or in combination with insulin glargine in Chinese patients with type 2 diabetes mellitus who are inadequately controlled with oral antihyperglycemic therapy: A multicenter, open‐label, randomized trial

Journal of Diabetes2023-10-208 citations